Lack of patient-centered evaluation of outcomes in intermittent claudication literature
Journal of Vascular Surgery · 2023
DOI: 10.1016/j.jvs.2023.03.497 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Vascular Surgery, 2023. Verfasst von Leigh Ann O'Banion und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, Department of Surgery, University of California San Francisco-Fresno, Fresno, CA. Electronic address: leighann.o'banion…. Hauptthemen laut MEDLINE: Intermittent Claudication, Peripheral Arterial Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Peripheral arterial disease, characterized as arterial atherosclerotic disease, can lead to insufficient flow in the lower extremities and ischemia, with the most common clinical manifestation being intermittent claudication (IC). In 2022, the Society for Vascular Surgery (SVS) developed appropriate use criteria for the management of IC that used this systematic review as a source of evidence. The objective of this study is to synthesize the findings of the systematic review and identify evidence gaps. METHODS: A comprehensive search of literature databases including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus was conducted from January 1, 2000, to November 30, 2022. Noncomparative and comparative observational studies and randomized controlled trials were included. Included studies evaluated exercise therapy, endovascular or open revascularization for the treatment of IC. Outcomes of interest (freedom from major adverse limb event, health-related quality of life, and walking distance) were compared in various subgroups (age, sex, diabetes, smoking status, anatomical location of disease, and optimal medical therapy). RESULTS: Twenty-six studies reported the outcomes of interest for the evidence map. The general conclusions of the studies that reported freedom from major adverse limb events were that reintervention rates for endovascular therapy at ≥2 years were >20%, major amputation rates were often not reported, and, after endovascular therapy, the 1-month mortality was low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular Surgery, Department of Surgery, University of California San Francisco-Fresno, Fresno, CA. Electronic address: leighann.o'banion@ucsf.edu.
- Evidence-Based Practice Center, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
- Division of Vascular and Endovascular Surgery, University of Massachusetts Chan Medical School, Worcester, MA.
- Division of Vascular Surgery, Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Zitieren
APA
O'Banion, L. A., Saadi, S., Hasan, B., Nayfeh, T., Simons, J. P., Murad, M. H., & Woo, K. (2023). Lack of patient-centered evaluation of outcomes in intermittent claudication literature. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2023.03.497
Vancouver
O'Banion LA, Saadi S, Hasan B, Nayfeh T, Simons JP, Murad MH, et al. Lack of patient-centered evaluation of outcomes in intermittent claudication literature. Journal of Vascular Surgery. 2023. doi:10.1016/j.jvs.2023.03.497
BibTeX
@article{OBanion2023,
author = {O'Banion, Leigh Ann and Saadi, Samer and Hasan, Bashar and Nayfeh, Tarek and Simons, Jessica P and Murad, Mohammad H and Woo, Karen},
title = {Lack of patient-centered evaluation of outcomes in intermittent claudication literature},
journal = {Journal of Vascular Surgery},
year = {2023},
doi = {10.1016/j.jvs.2023.03.497}
}
EUVIMED